Rebecca Kahn

2.8k total citations
45 papers, 978 citations indexed

About

Rebecca Kahn is a scholar working on Modeling and Simulation, Infectious Diseases and Epidemiology. According to data from OpenAlex, Rebecca Kahn has authored 45 papers receiving a total of 978 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Modeling and Simulation, 25 papers in Infectious Diseases and 13 papers in Epidemiology. Recurrent topics in Rebecca Kahn's work include COVID-19 epidemiological studies (26 papers), SARS-CoV-2 and COVID-19 Research (17 papers) and Vaccine Coverage and Hesitancy (11 papers). Rebecca Kahn is often cited by papers focused on COVID-19 epidemiological studies (26 papers), SARS-CoV-2 and COVID-19 Research (17 papers) and Vaccine Coverage and Hesitancy (11 papers). Rebecca Kahn collaborates with scholars based in United States, Sierra Leone and Switzerland. Rebecca Kahn's co-authors include Marc Lipsitch, Caroline O. Buckee, Ruoran Li, Michael J. Mina, Yonatan H. Grad, Corey M. Peak, Lauren M. Childs, Inga Holmdahl, Lee Kennedy‐Shaffer and Jennifer R. Verani and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Rebecca Kahn

43 papers receiving 952 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rebecca Kahn United States 18 523 498 204 200 93 45 978
Cécile Tran Kiem France 11 488 0.9× 491 1.0× 138 0.7× 105 0.5× 143 1.5× 20 889
Kylie E. C. Ainslie United Kingdom 14 530 1.0× 478 1.0× 225 1.1× 136 0.7× 157 1.7× 35 950
Maimuna S. Majumder United States 21 365 0.7× 508 1.0× 288 1.4× 170 0.8× 164 1.8× 51 1.2k
Alessio Andronico France 12 528 1.0× 468 0.9× 169 0.8× 93 0.5× 131 1.4× 18 939
Ambrose Talisuna Republic of the Congo 16 588 1.1× 338 0.7× 187 0.9× 245 1.2× 93 1.0× 57 1.1k
Zachary J. Madewell United States 11 592 1.1× 487 1.0× 171 0.8× 178 0.9× 59 0.6× 51 995
Akhona Tshangela Ethiopia 9 339 0.6× 276 0.6× 268 1.3× 182 0.9× 108 1.2× 17 823
Steven Abrams Belgium 17 303 0.6× 290 0.6× 243 1.2× 145 0.7× 76 0.8× 73 829
Caitlin Rivers United States 15 567 1.1× 494 1.0× 257 1.3× 94 0.5× 73 0.8× 31 1.2k
Valentina Marziano Italy 15 436 0.8× 483 1.0× 210 1.0× 164 0.8× 102 1.1× 36 903

Countries citing papers authored by Rebecca Kahn

Since Specialization
Citations

This map shows the geographic impact of Rebecca Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Kahn more than expected).

Fields of papers citing papers by Rebecca Kahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Kahn. The network helps show where Rebecca Kahn may publish in the future.

Co-authorship network of co-authors of Rebecca Kahn

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca Kahn. A scholar is included among the top collaborators of Rebecca Kahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca Kahn. Rebecca Kahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kahn, Rebecca, Benild Moiane, Fernanda C. Lessa, et al.. (2025). Nasopharyngeal carriage of Streptococcus pneumoniae among children and their household members in southern Mozambique five years after PCV10 introduction. Vaccine. 47. 126691–126691. 1 indexed citations
2.
Kahn, Rebecca, Daniel R. Feikin, Ryan E. Wiegand, & Marc Lipsitch. (2023). EXAMINING BIAS FROM DIFFERENTIAL DEPLETION OF SUSCEPTIBLES IN VACCINE EFFECTIVENESS ESTIMATES IN SETTINGS OF WANING. American Journal of Epidemiology. 193(1). 232–234. 1 indexed citations
3.
4.
Holmdahl, Inga, Rebecca Kahn, Kara Jacobs Slifka, Kathleen Dooling, & Rachel B. Slayton. (2022). Modeling the Impact of Vaccination Strategies for Nursing Homes in the Context of Increased Severe Acute Respiratory Syndrome Coronavirus 2 Community Transmission and Variants. Clinical Infectious Diseases. 75(1). e880–e883. 10 indexed citations
5.
Kahn, Rebecca, Stephanie J. Schrag, Jennifer R. Verani, & Marc Lipsitch. (2022). Identifying and Alleviating Bias Due to Differential Depletion of Susceptible People in Postmarketing Evaluations of COVID-19 Vaccines. American Journal of Epidemiology. 191(5). 800–811. 43 indexed citations
6.
Kahn, Rebecca, et al.. (2021). Leveraging Pathogen Sequence and Contact Tracing Data to Enhance Vaccine Trials in Emerging Epidemics. Epidemiology. 32(5). 698–704. 3 indexed citations
7.
Kahn, Rebecca, Inga Holmdahl, Sujan Reddy, et al.. (2021). Mathematical Modeling to Inform Vaccination Strategies and Testing Approaches for Coronavirus Disease 2019 (COVID-19) in Nursing Homes. Clinical Infectious Diseases. 74(4). 597–603. 30 indexed citations
8.
Greene, Sharon K., Sarah F. McGough, Gretchen M. Culp, et al.. (2021). Nowcasting for Real-Time COVID-19 Tracking in New York City: An Evaluation Using Reportable Disease Data From Early in the Pandemic. JMIR Public Health and Surveillance. 7(1). e25538–e25538. 23 indexed citations
9.
Kahn, Rebecca, et al.. (2021). Variation in human mobility and its impact on the risk of future COVID-19 outbreaks in Taiwan. BMC Public Health. 21(1). 226–226. 44 indexed citations
10.
Bushman, Mary, Rebecca Kahn, Bradford P. Taylor, Marc Lipsitch, & William P. Hanage. (2021). Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape. Cell. 184(26). 6229–6242.e18. 51 indexed citations
11.
Kahn, Rebecca, et al.. (2021). Examining SARS-CoV-2 Interventions in Residential Colleges Using an Empirical Network. International Journal of Infectious Diseases. 113. 325–330. 11 indexed citations
12.
Lipsitch, Marc & Rebecca Kahn. (2021). Interpreting vaccine efficacy trial results for infection and transmission. Vaccine. 39(30). 4082–4088. 41 indexed citations
13.
Greene, Sharon K., Alison Levin‐Rector, Emily McGibbon, et al.. (2021). Reduced COVID-19 hospitalizations among New York City residents following age-based SARS-CoV-2 vaccine eligibility: Evidence from a regression discontinuity design. Vaccine X. 10. 100134–100134. 7 indexed citations
14.
Kahn, Rebecca, Corey M. Peak, Juan Fernández-Gracia, et al.. (2020). Incubation periods impact the spatial predictability of cholera and Ebola outbreaks in Sierra Leone. Proceedings of the National Academy of Sciences. 117(9). 5067–5073. 21 indexed citations
15.
Kahn, Rebecca, Lee Kennedy‐Shaffer, Yonatan H. Grad, James M. Robins, & Marc Lipsitch. (2020). Potential Biases Arising From Epidemic Dynamics in Observational Seroprotection Studies. American Journal of Epidemiology. 190(2). 328–335. 10 indexed citations
16.
17.
Kahn, Rebecca. (2020). The COVID-19 is prompting many museums to reconsider how they communicate their research to the public. Zenodo (CERN European Organization for Nuclear Research). 2 indexed citations
18.
Kahn, Rebecca, et al.. (2019). Strengthening provision of essential medicines to women and children in post-Ebola Sierra Leone. Journal of Global Health. 9(1). 10307–10307. 5 indexed citations
19.
Schwartzman, Kevin, Claire Boone, Danielle Cazabon, et al.. (2018). Proximate determinants of tuberculosis in Indigenous peoples worldwide: a systematic review. The Lancet Global Health. 7(1). e68–e80. 33 indexed citations
20.
Kahn, Rebecca, Annette Rid, Peter G. Smith, Nir Eyal, & Marc Lipsitch. (2018). Choices in vaccine trial design in epidemics of emerging infections. PLoS Medicine. 15(8). e1002632–e1002632. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cécile Tran Kiem Breakdown of academic impact, for papers by Kylie E. C. Ainslie Breakdown of academic impact, for papers by Maimuna S. Majumder Breakdown of academic impact, for papers by Alessio Andronico Breakdown of academic impact, for papers by Ambrose Talisuna Breakdown of academic impact, for papers by Zachary J. Madewell Breakdown of academic impact, for papers by Akhona Tshangela Breakdown of academic impact, for papers by Steven Abrams Breakdown of academic impact, for papers by Caitlin Rivers Breakdown of academic impact, for papers by Valentina Marziano
Rankless by CCL
2026